本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ascendis Pharma A/S

235.93
-28.9950-10.94%
成交量:42.48萬
成交額:1.02億
市值:156.16億
市盈率:18.20
高:257.53
開:256.25
低:232.02
收:264.92
52周最高:282.15
52周最低:186.05
股本:6,618.99萬
流通股本:6,553.95萬
量比:7.65
換手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):12.96
每股收益(LYR):-4.4176
淨資產收益率:118.78%
總資產收益率:9.58%
市淨率:9.42
市盈率(LYR):-53.41

資料載入中...

2026/09/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities